BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) Live Share Price, Invest From India

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Performance

as on October 24, 2026 at 6:10 am IST

Day's High
$0.89
Day's Price Range
$0.90
$0.89
1.12%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.89
100.00%
Downside
-100.00%
Upside

BriaCell Therapeutics Corp. Warrant expiring 2031 share price movements today

Previous Close: $0.90
Open: $0.90
Volume: 64.5K
Day's Low - High: $0.89 - $0.90

BriaCell Therapeutics Corp. Warrant expiring 2031 Historical Returns

1 Month Return: -10.65 %
3 Month Return: + 2.56 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics Corp. Warrant expiring 2031 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

-175.26%

BriaCell Therapeutics Corp. Warrant expiring 2031 stock Key Stats

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics Corp. Warrant expiring 2031 with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BriaCell Therapeutics Corp. Warrant expiring 2031	NA	$-	NA	NA	0.00%	0.00%

Indian Investors' Interest in BriaCell Therapeutics Corp. Warrant expiring 2031 Stock

Search interest for BriaCell Therapeutics Corp. Warrant expiring 2031 Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:50% versus previous 30 day period

About BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Organisation	BriaCell Therapeutics Corp. Warrant expiring 2031
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Industry	Miscellaneous
CEO	Dr. William V. Williams FCPA, M.D.

Key Management of BriaCell Therapeutics Corp. Warrant expiring 2031

Name	Title
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H.	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. William V. Williams FCPA, M.D.	CEO, President & Director

FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2031 share price today?

BriaCell Therapeutics Corp. Warrant expiring 2031 share price today is $0.89 as on October 24, 2026 at 12:40 am IST. BriaCell Therapeutics Corp. Warrant expiring 2031 share today touched a day high of $0.90 and a low of $0.89.

What is the 52 week high and 52 week low for BriaCell Therapeutics Corp. Warrant expiring 2031 share?

BriaCell Therapeutics Corp. Warrant expiring 2031 share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. BriaCell Therapeutics Corp. Warrant expiring 2031 stock price today i.e. October 24, 2026 at 12:40 am IST is trending at $0.89,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in BriaCell Therapeutics Corp. Warrant expiring 2031 Stock (BCTXL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BriaCell Therapeutics Corp. Warrant expiring 2031 on INDmoney app. Click on Buy button.

What is the minimum amount required to buy BriaCell Therapeutics Corp. Warrant expiring 2031 Stock (BCTXL) from India?

Indian investors can start investing in BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 12:57 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in BriaCell Therapeutics Corp. Warrant expiring 2031 stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 12:57 am IST). Based on BriaCell Therapeutics Corp. Warrant expiring 2031 share’s latest price of $0.89 as on October 24, 2026 at 12:40 am IST, you will get 11.2360 shares of BriaCell Therapeutics Corp. Warrant expiring 2031. Learn more about fractional shares .